KCT0007499
Completed
未知
A 12 week, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of MC01 on the Skin Wrinkle Improvement and Moisturizing
Maeil Health Nutrition0 sites100 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the skin and subcutaneous tissue
- Sponsor
- Maeil Health Nutrition
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) men and women between the ages of 40 and 60
- •2\) In visual assessment, Those with grade 3 or higher on both the left and right eye wrinkles
- •3\) Those with water retention of both cheeks measured with Corneometer® of 49 AU or less in visit 1and visit 2
- •4\) Befor Clinicla Trial, A person who agrees to participate in Clinical Trial, and write informed consent form.
Exclusion Criteria
- •1\) Persons currently being treated for severe cardiovascular, immune, respiratory system, gastrointestinal/hepatic and biliary systems, kidney and urological systems, nervous system, musculoskeletal system, infectious diseases and malignancies
- •2\) A person with mental illness such as schizophrenia, depression, drug addiction, alcohol use/inducing disorder, etc
- •3\) People with skin diseases such as atopic dermatitis and psoriasis
- •4\) Those who have skin abnormalities such as spots, acne, erythema, capillary dilatation, etc. in the test area
- •5\) Smokers or persons less than one year after smoking cessation
- •6\) A person who has undergone a procedure such as Botox, filler, etc. on the face within 6 months of visit 1 or has undergone laser treatment, skin peeling, or other skin care on the face within 1 month (30 days)
- •7\) A person who has used a steroid\-containing skin exoplasmic agent in the facial area or has taken an oral retinoid/steroid within 3 months of visit 1
- •8\) A person who has taken obesity treatments (fat absorption inhibitors, appetite suppressants, etc.), psychiatric drugs such as depression and schizophrenia, contraceptives or hormone drugs, or diuretics within one month of visit 1
- •9\) A person who has taken medicines and health functional foods (antioxidants, hyaluronic acid, collagen, moonflower seed oil, vitamins A, C, E\-containing medicines and health functional foods) within 2 weeks of visit 1
- •10\) A person who has used functional cosmetics (retinoid agents, AHA, etc.), high\-moisturizing cosmetics, or skin care devices (LED masks, ion boosters, etc.) to improve wrinkles within 2 weeks of visit 1
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A 12 week, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of EDL on DyspepsiaDiseases of the digestive systemKCT0005229ovaKmed100
Completed
Not Applicable
A 12 Week, Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of NVP-2106 on improvement of Cognitive FunctioKCT0009187VP Healthcare120
Active, not recruiting
Not Applicable
Clinical Trial for the Evaluation of the Efficacy and Safety of L. curvatus HY7601 and L. plantarum KY1032 on Reducing body weight and body fat on Overweight or Obesity subjectsEndocrine, nutritional and metabolic diseasesKCT0007117Vievis NAMUH Hospital72
Active, not recruiting
Not Applicable
The Efficacy and Safety of MKC on the Skin Wrinkle Improvement and MoisturizingKCT0006416Holistic Bio100
Completed
Not Applicable
A 12 week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of Lactobacillus plantarum LMT1-48 on Reducing Body FatEndocrine, nutritional and metabolic diseasesKCT0008055Global Medical Research Center120